Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase subunit E (AtpE) is a small integral membrane protein that forms part of the F₀ motor of the ATP synthase complex, primarily in prokaryotes and mitochondria. ATP synthase is a molecular rotary motor responsible for synthesizing ATP from ADP and inorganic phosphate using the proton gradient generated during cellular respiration. AtpE plays a critical role in the structural integrity and function of the F₀ portion, coupling proton flow through the membrane with rotation of the enzyme and thus enabling ATP production. In Mycobacterium tuberculosis, AtpE is an essential enzyme—making it a validated drug target for novel antimycobacterial agents such as bedaquiline, which bind specifically and inhibit its activity, causing cell death due to energy starvation.
Inhibition of ATP synthase activity via interference with proton translocation and ATP generation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase subunit E (AtpE).